Ketamine for Treatment Resistant Late-Life Depression
Status:
Completed
Trial end date:
2020-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effectiveness of a single infusion of ketamine
(KET), to determine which dose is optimal 7 days after infusion using Bayesian Adaptive
Randomization, and to learn about how ketamine works in the body and brain in persons with
late-life treatment resistant depression.